NCT04515680View on ClinicalTrials.gov

Endocrine Function During Deferasirox Therapy

CompletedOBSERVATIONAL
Enrollment

426

Participants

Timeline

Start Date

November 2, 2016

Primary Completion Date

January 30, 2019

Study Completion Date

January 30, 2019

Conditions
Iron OverloadTransfusion-dependent ThalassemiaEndocrine; Complications
Trial Locations (1)

80138

Università degli Studi della Campania Luigi Vanvitelli, Naples

All Listed Sponsors
lead

University of Campania Luigi Vanvitelli

OTHER

NCT04515680 - Endocrine Function During Deferasirox Therapy | Biotech Hunter | Biotech Hunter